Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection
Public ClinicalTrials.gov record NCT00096785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection
Study identification
- NCT ID
- NCT00096785
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Interventions
- entecavir Drug
- adefovir Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2004
- Primary completion
- Dec 31, 2005
- Completion
- Mar 31, 2008
- Last update posted
- Aug 9, 2010
2004 – 2008
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | San Diego | California | — | — |
| Local Institution | San Francisco | California | — | — |
| Local Institution | Torrance | California | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | North Miami Beach | Florida | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Insitution | New York | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Galveston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00096785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2010 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00096785 live on ClinicalTrials.gov.